DS-1001b

· Daiichi Sankyo Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DS-1001b, covering 2026-02-04 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated WHO Grade II Glioma [Phase 2]

See pricing